View Older Stories View More Recent Stories

Nov 8, 2016 08:05PM Arrowhead Pharmaceuticals Provides Update on Heparc-2004 Study
Nov 1, 2016 07:30AM Arrowhead Pharmaceuticals to Present at Upcoming Conferences
Oct 20, 2016 10:00AM Arrowhead Pharmaceuticals to Present Data on ARC-AAT at The Liver Meeting®
Oct 6, 2016 09:22AM Pre-Open Stock Movers 10/06: (ALQA) (SCYX) (ZUMZ) Higher; (ALNY) (TWTR) (MDCO) Lower (more...)
Oct 6, 2016 07:32AM Arrowhead Research (ARWR),Spring Bank Pharma (SBPH) Enter Collaboration on Chronic HBV Treatments Development
Oct 6, 2016 07:30AM Arrowhead and Spring Bank Announce Clinical Collaboration for ARC-520 and SB 9200 in Chronic Hepatitis B
Sep 29, 2016 07:31AM Amgen (AMGN), Arrowhead Pharma (ARWR) Enter Two Cardiovascular-Focused License, Collaboration Agreements
Sep 29, 2016 07:31AM Amgen (AMGN), Arrowhead Pharmaceuticals (ARWR) Enter Collaborations on Two Cardiovascular Therapies
Sep 29, 2016 07:30AM Amgen And Arrowhead Pharmaceuticals Announce Two Cardiovascular Collaborations
Sep 7, 2016 07:30AM Arrowhead Pharmaceuticals Doses First Patient with Hepatitis B in Multiple Ascending Dose Portion of Phase 1/2 Study of ARC-521
Sep 6, 2016 07:31AM Arrowhead Research (ARWR) Initiated Phase 2 Clinical Study of ARC-AAT in AATD
Sep 6, 2016 07:30AM Arrowhead Pharmaceuticals Initiates Phase 2 Study of ARC-AAT
Sep 1, 2016 07:30AM Arrowhead Pharmaceuticals to Present at Upcoming September Conferences
Aug 12, 2016 07:30AM Arrowhead Pharmaceuticals Closes $45 Million Private Offering
Aug 9, 2016 04:01PM Arrowhead Reports Fiscal 2016 Third Quarter Results
Aug 9, 2016 09:06AM Arrowhead Research (ARWR) Prices $45M Private Stock Offering at $5.90/Share
Aug 9, 2016 09:01AM Arrowhead Pharmaceuticals Prices $45 Million Private Offering
Aug 1, 2016 04:01PM Arrowhead Pharmaceuticals to Webcast Fiscal 2016 Third Quarter Results
Jul 6, 2016 07:30AM Arrowhead Pharmaceuticals to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference
Jun 9, 2016 07:39AM Arrowhead Research (ARWR) Begins Phase 1/2 Single and Multiple Dose Study of HBV Candidate ARC-521
Jun 9, 2016 07:30AM Arrowhead Pharmaceuticals Initiates Phase 1/2 Single and Multiple Dose Study of Hepatitis B Candidate ARC-521
Jun 3, 2016 07:30AM Arrowhead Pharmaceuticals to Present at the Jefferies 2016 Healthcare Conference
May 10, 2016 04:01PM Arrowhead Reports Fiscal 2016 Second Quarter Results
May 6, 2016 12:00PM Arrowhead Pharmaceuticals’ Preclinical Candidate ARC-LPA Achieves 98% Knockdown and Long Duration of Effect after Subcutaneous Administration
May 3, 2016 04:01PM Arrowhead Pharmaceuticals to Webcast Fiscal 2016 Second Quarter Results
Apr 29, 2016 07:30AM Arrowhead Pharmaceuticals to Present at Upcoming May Conferences
Apr 28, 2016 09:20AM Arrowhead Research (ARWR) Files for Clearance to Begin Phase 1/2 Study of ARC-521
Apr 28, 2016 07:30AM Arrowhead Pharmaceuticals Files for Regulatory Clearance to Begin Phase 1/2 Study of ARC-521
Apr 18, 2016 02:01PM Arrowhead Research (ARWR) Says It Presented Preclinical Data on Renal Cell Carcinoma Program at AACR
Apr 18, 2016 02:00PM Arrowhead Pharmaceuticals Presents Preclinical Data on Renal Cell Carcinoma Program at AACR 2016
Apr 13, 2016 09:33AM Pre-Open Stock Movers 04/13: (RPRX) (ACUR) (MDVN) Higher; (CLVS) (VRX) (S) Lower (more...)
Apr 13, 2016 07:33AM Arrowhead Research (ARWR) Will Make Three Presentations on ARC-520 at ILC 2016
Apr 13, 2016 07:30AM Arrowhead Pharmaceuticals Presents Promising ARC-520 Hepatitis B Data at The International Liver Congress™ 2016
Apr 6, 2016 04:02PM Arrowhead Research (ARWR) Becomes Arrowhead Pharmaceuticals
Apr 6, 2016 04:01PM Arrowhead Research Changes Name to Arrowhead Pharmaceuticals
Mar 30, 2016 07:30AM Arrowhead to Present at Upcoming April Conferences
Mar 7, 2016 12:52PM Arrowhead Research (ARWR) Presents New Preclinical Data on ARC-F12 at AAAAI
Mar 7, 2016 12:45PM Arrowhead Presents Promising New Preclinical Data on ARC-F12 at AAAAI 2016
Mar 1, 2016 07:30AM Arrowhead to Present at Upcoming March Conferences
Feb 16, 2016 04:33PM Arrowhead to Present at Upcoming February Conferences
Feb 9, 2016 04:01PM Arrowhead Reports Fiscal 2016 First Quarter Results
Feb 2, 2016 04:01PM Arrowhead to Webcast Fiscal 2016 First Quarter Results
Jan 19, 2016 07:32AM Arrowhead Research (ARWR) Announces Receipt of EMA Orphan Drug Designation for ARC-AAT
Jan 19, 2016 07:30AM Arrowhead’s ARC-AAT Granted EMA Orphan Drug Designation
Jan 7, 2016 07:32AM Arrowhead Research (ARWR) Announces Dosing in ARC-520 Phase 2b MONARCH Study
Jan 7, 2016 07:30AM Arrowhead Begins Dosing the Phase 2b MONARCH Combination Study of ARC-520 in Patients with Chronic Hepatitis B Infection
Dec 14, 2015 04:01PM Arrowhead Reports Fiscal 2015 Year End Results
Dec 14, 2015 01:17PM Arrowhead Research (ARWR) to Join NASDAQ Biotechnology Index (NBI)
Dec 14, 2015 01:16PM Arrowhead Added to NASDAQ Biotechnology Index®
Dec 7, 2015 04:01PM Arrowhead to Webcast Fiscal 2015 Year End Results
View More Recent Stories View Older Stories